By a News Reporter-Staff News Editor at Robotics & Machine Learning -- SafeStitch Medical, Inc. (OTCBB: SFES), which recently merged with TransEnterix, Inc., a development stage medical device company that is pioneering the use of flexible instruments and robotics to improve how minimally invasive surgery is performed, announced that it has appointed Joseph P. Slattery to serve as its Executive Vice President and Chief Financial Officer, effective October 2, 2013. As previously announced, SafeStitch Medical is expected to be renamed TransEnterix, subject to stockholder approval. All references to TransEnterix in this release refer to the combined company.
Mr. Slattery brings a wealth of experience to the TransEnterix management team, having most recently served as Executive Vice President and Chief Financial Officer of Baxano Surgical, Inc, a medical device company focused on minimally invasive spine. Previously, he served as Chief Financial Officer and Senior Vice President of Finance and Information Systems of Digene Corporation, a molecular diagnostics company that was acquired by Qiagen, N.V. in August 2007. Mr. Slattery currently serves on the board of directors of CVRx, Inc., a privately-held medical device company and Exosome Diagnostics, a privately-held molecular diagnostics company.
"We are pleased to welcome Joe to the TransEnterix team," said Todd Pope, President and CEO of TransEnterix. "His strong background working with high growth medical technology companies will be invaluable as we develop and commercialize our SurgiBot surgical robotic system."
"I am excited to join TransEnterix at this stage of its development," commented Mr. Slattery. "The surgical robotic market presents a compelling opportunity for TransEnterix's novel patient-side robotic system." About SafeStitch Medical (TransEnterix) SafeStitch Medical (TransEnterix) is a development stage medical device company that is pioneering the use of flexible instruments and robotics to improve how minimally invasive surgery is performed. The Company is focused on the development and commercialization of SurgiBot, a novel patient side minimally invasive surgical robotic system. For more information, visit the company's websites at www.transenterix.com and www.safestitch.com.
Keywords for this news article include: Surgery, Robotics, Medical Devices, Machine Learning, SafeStitch Medical, Emerging Technologies, Investment and Finance.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC